BNP Paribas Arbitrage SA boosted its holdings in shares of Cerner Corporation (NASDAQ:CERN) by 94.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 189,488 shares of the company’s stock after purchasing an additional 92,065 shares during the period. BNP Paribas Arbitrage SA owned about 0.06% of Cerner Corporation worth $13,514,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Alps Advisors Inc. increased its holdings in Cerner Corporation by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 8,693 shares of the company’s stock valued at $578,000 after purchasing an additional 23 shares during the period. Laurel Wealth Advisors Inc. increased its holdings in Cerner Corporation by 0.6% during the 2nd quarter. Laurel Wealth Advisors Inc. now owns 3,909 shares of the company’s stock valued at $259,000 after purchasing an additional 24 shares during the period. Conning Inc. increased its holdings in Cerner Corporation by 0.8% during the 2nd quarter. Conning Inc. now owns 7,742 shares of the company’s stock valued at $515,000 after purchasing an additional 58 shares during the period. ProVise Management Group LLC increased its holdings in Cerner Corporation by 1.3% during the 2nd quarter. ProVise Management Group LLC now owns 5,184 shares of the company’s stock valued at $345,000 after purchasing an additional 69 shares during the period. Finally, Advisory Services Network LLC increased its holdings in Cerner Corporation by 4.4% during the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after purchasing an additional 70 shares during the period. Institutional investors own 78.26% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Cerner Corporation (CERN) Shares Bought by BNP Paribas Arbitrage SA” was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/11/14/cerner-corporation-cern-shares-bought-by-bnp-paribas-arbitrage-sa.html.

In other Cerner Corporation news, Chairman Clifford W. Illig sold 4,000 shares of the business’s stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $65.96, for a total transaction of $263,840.00. Following the completion of the sale, the chairman now directly owns 1,229,719 shares in the company, valued at approximately $81,112,265.24. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Randy D. Sims sold 60,000 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $68.03, for a total transaction of $4,081,800.00. Following the sale, the senior vice president now owns 60,890 shares of the company’s stock, valued at $4,142,346.70. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 257,470 shares of company stock valued at $17,695,482. 13.20% of the stock is owned by company insiders.

Cerner Corporation (NASDAQ:CERN) opened at $65.47 on Tuesday. Cerner Corporation has a 1-year low of $47.01 and a 1-year high of $73.86. The firm has a market cap of $21,710.02, a P/E ratio of 28.90, a P/E/G ratio of 2.10 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75.

Cerner Corporation (NASDAQ:CERN) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). Cerner Corporation had a return on equity of 18.03% and a net margin of 13.37%. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the previous year, the firm earned $0.59 earnings per share. Cerner Corporation’s revenue was up 7.7% on a year-over-year basis. analysts anticipate that Cerner Corporation will post 2.26 earnings per share for the current year.

A number of research analysts recently issued reports on CERN shares. Royal Bank Of Canada restated a “buy” rating on shares of Cerner Corporation in a report on Wednesday, October 25th. Robert W. Baird restated a “hold” rating and set a $67.00 price target on shares of Cerner Corporation in a report on Thursday, August 31st. Cantor Fitzgerald restated a “buy” rating and set a $77.00 price target on shares of Cerner Corporation in a report on Tuesday, October 10th. J P Morgan Chase & Co cut Cerner Corporation from an “overweight” rating to a “neutral” rating in a research report on Friday, October 27th. Finally, Zacks Investment Research cut Cerner Corporation from a “buy” rating to a “sell” rating in a research report on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $69.79.

About Cerner Corporation

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Corporation (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner Corporation (NASDAQ:CERN)

Receive News & Ratings for Cerner Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corporation and related companies with MarketBeat.com's FREE daily email newsletter.